Category
Cancer
Sub Category
Prostate
Study Name
RTOG 1115: Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist VS. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 for Men With High Risk Prostate Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance